Meridian Bioscience reported $25M in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Abbott ABT:US $ 17090M 960M
Accelerate Diagnostics AXDX:US 116.08M 8.02M
Atrion ATRI:US 0 0
Becton, Dickinson and BDX:US $ 18635M 1211M
Bio Rad Laboratories BIO:US $ 1197.24M 1186.24M
Cerulean Pharma CERU:US $ 0M 0M
Cerus CERS:US $ 69.78M 0.36M
Meridian Bioscience VIVO:US $ 25M 25M
Myriad Genetics MYGN:US $ 0M 0M
Orasure Technologies OSUR:US $ 2.91M 0.02M
Quidel QDEL:US $ 0M 0M
Sientra SIEN:US $ 70.84M 6.07M
Staar Surgical STAA:US $ 0.49M 0.02M
Thermo Fisher Scientific TMO:US $ 33255M 1615M
Trinity Biotech TRIB:US $ 76.46M 22.7M
Utah Medical Products UTMD:US 0 0